Marshall Islands vs Pakistan: Share of children with symptoms of a respiratory infection who received antibiotics
Marshall Islands
50.1%
in 2018
Pakistan
49.9%
in 2018
Marshall Islands rank
69th
Pakistan rank
70th
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Marshall Islands
- Pakistan
How they compare
Marshall Islands currently reports 50.1% against 49.9% in Pakistan, a difference of 0.2%.
The two have swapped places 3 times across 19 shared years of data; in 2000 it was Pakistan ahead.
Marshall Islands ranks 69th and Pakistan ranks 70th of 132 countries.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 57.4% | 7.4% | Pakistan |
| 2010s | 49.8% | 53.8% | 4.0% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Marshall Islands or Pakistan?
- Marshall Islands, at 50.1% against 49.9% in Pakistan as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Marshall Islands and Pakistan?
- 0.2%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Pakistan?
- 19 years are reported by both, from 2000 to 2018.
- How do Marshall Islands and Pakistan rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Marshall Islands ranks 69th and Pakistan ranks 70th of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.